The estimated Net Worth of John William Larson is at least 5.81 百万$ dollars as of 28 November 2017. John Larson owns over 30,500 units of Sangamo Therapeutics Inc stock worth over 53,491$ and over the last 20 years John sold SGMO stock worth over 5,757,315$.
John has made over 55 trades of the Sangamo Therapeutics Inc stock since 2004, according to the Form 4 filled with the SEC. Most recently John exercised 30,500 units of SGMO stock worth 179,645$ on 28 November 2017.
The largest trade John's ever made was exercising 49,250 units of Sangamo Therapeutics Inc stock on 11 May 2016 worth over 599,373$. On average, John trades about 6,638 units every 65 days since 2004. As of 28 November 2017 John still owns at least 63,680 units of Sangamo Therapeutics Inc stock.
You can see the complete history of John Larson stock trades at the bottom of the page.
John's mailing address filed with the SEC is C/O SANGAMO BIOSCIENCES IN STE.A-100, POINT RICHMOND TECH CENTER 501 CANA BLVD, RICHMOND, CA, 94804.
Over the last 24 years, insiders at Sangamo Therapeutics Inc have traded over 87,969,621$ worth of Sangamo Therapeutics Inc stock and bought 3,434,008 units worth 48,483,268$ . The most active insiders traders include Capital Management, L.P.Ra ...、Le Roy C Kopp、Inc.Biogen Ma Inc. Biogen. On average, Sangamo Therapeutics Inc executives and independent directors trade stock every 21 days with the average trade being worth of 40,671$. The most recent stock trade was executed by Inc.Biogen Ma Inc. Biogen on 26 September 2023, trading 6,000,000 units of SGMO stock currently worth 3,000,000$.
for sangamo therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. to learn more about sangamo, visit the our website at www.sangamo.com.
Sangamo Therapeutics Inc executives and other stock owners filed with the SEC include: